This site is best viewed with Internet Explorer 8 or greater, or Firefox 3.5 or greater. Click the icon below to upgrade to a suitable browser version.


Close

PanCan news



Syndicate content pancreatic cancer - Google News
Google News
Updated: 1 day 16 hours ago

Henry Ford Health System gets $20 million gift for pancreatic cancer research - ModernHealthcare.com

Mon, 2018-04-09 10:42

ModernHealthcare.com

Henry Ford Health System gets $20 million gift for pancreatic cancer research
ModernHealthcare.com
Expanding the number of identified biomarkers in pancreatic cancer that can be validated in patients diagnosed with pancreatic cancer; Translating those biomarkers into screening tests to detect pancreatic cancer earlier; Utilizing artificial ...
$20M Gift Seeks to Speed Detection of Pancreatic CancerU.S. News & World Report
Henry Ford gets $20M to target earlier cancer detectionThe Detroit News
Henry Ford Health System receives $20 million gift to launch pancreatic cancer centerWXYZ
WDIV ClickOnDetroit
all 17 news articles »

Health Matters: Pancreatic Cancer, What you Need to Know - NBC-2 ... - NBC2 News

Mon, 2018-04-09 09:44

NBC2 News

Health Matters: Pancreatic Cancer, What you Need to Know - NBC-2 ...
NBC2 News
In the early stages, doctors say pancreatic cancer typically has no symptoms. “The tumor is the same no matter where it is in the pancreas, but the symptoms vary, and because of that the outcomes vary,” said Dr. Mark Bloomston, a surgical oncologist on ...

and more »

$20M gift seeks to speed detection of pancreatic cancer - The Seattle Times

Mon, 2018-04-09 06:27

WXYZ

$20M gift seeks to speed detection of pancreatic cancer
The Seattle Times
DETROIT (AP) — Henry Ford Health System says a $20 million gift will help launch a center to develop new methods to detect pancreatic cancer earlier. The Detroit-based health system announced Monday that the gift for the Henry Ford Pancreatic Cancer ...
Henry Ford Health System receives $20 million anonymous ...WXYZ
Donor gives $20 million to Henry Ford Health System for pancreatic ...Detroit Free Press

all 15 news articles »

Global Pancreatic Cancer Partnering Deals & Agreements (2012-2018) Entered Into by the World's Leading Healthcare ... - PR Newswire (press release)

Mon, 2018-04-09 05:34

Global Pancreatic Cancer Partnering Deals & Agreements (2012-2018) Entered Into by the World's Leading Healthcare ...
PR Newswire (press release)
The "Global Pancreatic Cancer Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering. The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare ...

and more »

Novel technology gives rise to mouse pancreatic tumors that ... - News-Medical.net

Fri, 2018-04-06 03:56

News-Medical.net

Novel technology gives rise to mouse pancreatic tumors that ...
News-Medical.net
Novel technology developed at UT Health San Antonio gives rise to mouse pancreatic tumors that have the same traits as human pancreatic cancer. A U.S. patent is pending on the invention.

and more »

Mayo needs recruits in study to help fight pancreatic cancer - La Crosse's NewsTalk 1410AM 92.3FM

Fri, 2018-04-06 02:22

EurekAlert (press release)

Mayo needs recruits in study to help fight pancreatic cancer
La Crosse's NewsTalk 1410AM 92.3FM
Those recruited will take blood samples over a three-year period to develop screening tools to catch the disease early. The American Cancer Society says a five-year survival rate is just 7 percent. “What we're looking for is blood tests that will allow ...
£1 million funds 7 grants for pancreatic cancer research | EurekAlert ...EurekAlert (press release)

all 5 news articles »

£1 million funds 7 grants for pancreatic cancer research | EurekAlert ... - EurekAlert (press release)

Thu, 2018-04-05 23:03

EurekAlert (press release)

£1 million funds 7 grants for pancreatic cancer research | EurekAlert ...
EurekAlert (press release)
Seven research projects have been awarded grants totaling £1.1 million by the UK medical research charity, Pancreatic Cancer Research Fund (PCRF). The grants bring the charity's total research support to £10 million.

and more »

Injecting Gene Cocktail into Mouse Pancreas Leads to Humanlike Tumours - Scicasts (press release) (blog)

Thu, 2018-04-05 14:41

EurekAlert (press release)

Injecting Gene Cocktail into Mouse Pancreas Leads to Humanlike Tumours
Scicasts (press release) (blog)
San Antonio, TX (Scicasts) — Novel technology developed at UT Health San Antonio gives rise to mouse pancreatic tumours that have the same traits as human pancreatic cancer. A U.S. patent is pending on the invention. The technology could revolutionize ...
Injecting gene cocktail into mouse pancreas leads to humanlike tumorsEurekAlert (press release)

all 1 news articles »

Mayo-Franciscan to enlist diabetes patients in pancreatic cancer study - La Crosse Tribune

Thu, 2018-04-05 08:37

La Crosse Tribune

Mayo-Franciscan to enlist diabetes patients in pancreatic cancer study
La Crosse Tribune
Mayo Clinic Health System-Franciscan Healthcare in La Crosse and Mayo Clinic Health System in Eau Claire are recruiting diabetes patients for a Mayo Clinic study that aims to discover the.
New study looking for ways to screen and detect pancreatic cancer soonerWXOW.com

all 3 news articles »

Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort ... - Dove Medical Press

Wed, 2018-04-04 20:41

Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort ...
Dove Medical Press
Further analyses based on the adjusted potential confounders were conducted, including CA199, neutrophil-to-lymphocyte ratio, modified Glasgow Prognostic Score, albumin, C-reactive protein, Eastern Cooperative Oncology Group, stage, tumor size, nodal ...

Second-Line Decision-Making in Pancreatic Cancer - OncLive

Tue, 2018-04-03 14:09

Second-Line Decision-Making in Pancreatic Cancer
OncLive
Kenneth H. Yu, MD: When I consider second-line therapy for patients with advanced pancreatic cancer, a lot of it depends on what treatment they received in the frontline setting. Then, again, we must always consider the clinical situation. What's the ...

and more »

Cancer docs say 'superblood' may work against deadly malignancies - NBCNews.com

Mon, 2018-04-02 14:34

NBCNews.com

Cancer docs say 'superblood' may work against deadly malignancies
NBCNews.com
Some cancer scientists believe that doses of superblood could work against potentially deadly malignancies that are hard to treat with existing therapies. These include triple-negative breast cancer and pancreatic cancer as well as cancers of the liver ...

Early Data Supports Phase 3 Trial of Pegilodecakin in Pancreatic ... - Immuno-Oncology News

Mon, 2018-04-02 07:00

Immuno-Oncology News

Early Data Supports Phase 3 Trial of Pegilodecakin in Pancreatic ...
Immuno-Oncology News
ARMO Biosciences' immunotherapy candidate pegilodecakin (AM0010) was seen to be safe in the first interim analysis of a Phase 3 trial evaluating it as a possible treatment of metastatic pancreatic cancer, ensuring that the trial can proceed. According ...

and more »

Benefit concert raises awareness of pancreatic cancer - Newsplex - The Charlottesville Newsplex

Sat, 2018-03-31 16:51

The Charlottesville Newsplex

Benefit concert raises awareness of pancreatic cancer - Newsplex
The Charlottesville Newsplex
A family in Fluvanna County is remembering their late mother by raising money for pancreatic cancer research.

and more »

'Right to try' offers promising access to revolutionary treatments for cancer patients - The Hill

Fri, 2018-03-30 13:33

The Hill

'Right to try' offers promising access to revolutionary treatments for cancer patients
The Hill
Cancer is a scary word. Throughout the course of our lives, we share a 40 percent risk of developing some kind of cancer, and for one in five, it delivers an unwanted ending. Right now, Congress is taking a hard look at legislation that will make it ...

Bekaii-Saab Highlights Emerging Agents in Pancreatic Cancer Pipeline - OncLive

Fri, 2018-03-30 11:56

OncLive

Bekaii-Saab Highlights Emerging Agents in Pancreatic Cancer Pipeline
OncLive
The increasing incidence of pancreatic cancer could make the malignancy the second-leading cause of cancer-related death in the United States, making it imperative to find new treatment options, explains Tanios Bekaii-Saab, MD. PARP inhibitors are one ...

Bekaii-Saab Highlights Emerging Agents in Pancreatic Cancer Pipeline - OncLive

Fri, 2018-03-30 11:53

OncLive

Bekaii-Saab Highlights Emerging Agents in Pancreatic Cancer Pipeline
OncLive
The increasing incidence of pancreatic cancer could make the malignancy the second-leading cause of cancer-related death in the United States, making it imperative to find new treatment options, explains Tanios Bekaii-Saab, MD. PARP inhibitors are one ...

Local colon, pancreatic cancer survivor wants to raise awareness - WSFA

Thu, 2018-03-29 10:58

Local colon, pancreatic cancer survivor wants to raise awareness
WSFA
"You know when something like this comes up and you don't know the outcome, or the seriousness of it, it can kind of stun you.” Seale didn't know a lot about the disease, which her doctor says that isn't unusual. "One of the things I discovered when I ...

Westborough Run/Walk for Pancreatic Cancer Research to be held April 29 - Community Advocate

Thu, 2018-03-29 09:43

Community Advocate

Westborough Run/Walk for Pancreatic Cancer Research to be held April 29
Community Advocate
Westborough – The Westborough Tennis & Swim Club will host the ninth annual 5k/10k Walk/Run Sunday, April 29, to benefit the Lustgarten Foundation for Pancreatic Cancer Research. Registration will begin at 8 a.m. The 5k/10k will begin at 9:30 a.m. The ...
Local colon, pancreatic cancer survivor wants to raise awareness ...WAFF
10 things to know about rising rates of pancreatic cancerBecker's ASC Review
Antibiotics Make PDA Treatment More Effective in MiceSpecialty Pharmacy Times
Business Services -Herald Keeper -Belfast Live
all 8 news articles »

Promising Phase 2 Results Lead to Fast Track Designation for Pancreatic Cancer Drug - Oncology Nurse Advisor

Wed, 2018-03-28 12:07

Oncology Nurse Advisor

Promising Phase 2 Results Lead to Fast Track Designation for Pancreatic Cancer Drug
Oncology Nurse Advisor
FibroGen announced that the Food and Drug Administration (FDA) has granted Fast Track designation for pamrevlumab for the treatment of patients with locally advanced unresectable pancreatic cancer. Pamrevlumab is a first-in-class anti-connective tissue ...





Login

Connect with FaceBook


Website designed and developed by Uru Multimedia, and hosted by Chrysalis Hosting